Purchase Order 75N91023P00575
Award Date 6/27/23
Potential Completion Date 6/26/24
Potential Value $19K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Huntsville, AL 35806, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Irepertoire Inc. for $16,300 on September 21, 2020, with completion by October 30, 2020. The order is firm fixed price with no set-aside. Performance takes place in Huntsville, Alabama. The contractor will extract RNA, prepare cDNA, and sequence T-cell receptors from different mouse strains using multiplex PCR technology to quantitatively amplify cDNA of each T-cell receptor in provided tissue samples.</p>
- <p>The National Cancer Institute awarded a purchase order to Irepertoire Inc. for $6,525.00 on December 12, 2017, for RNA sequencing services. Performance is located in Bethesda, Maryland. The order is firm-fixed-price with an ultimate completion date of December 29, 2017. Irepertoire Inc. is a small disadvantaged business providing advanced molecular biology and immunological research services, with core expertise in T-cell receptor sequencing and deep immune repertoire analysis.</p>
- <p>The National Cancer Institute awarded a purchase order to Irepertoire Inc. for $4,350.00 on March 16, 2018, for AMP2SEQ service MiSeq per library MTAI-M and MTBI-M processing of six samples. Performance occurs in Bethesda, Maryland, with an ultimate completion date of April 30, 2018. Irepertoire Inc. is a small disadvantaged business specializing in molecular biology and immunological research services, including T-cell receptor sequencing and deep immune repertoire analysis.</p>
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Irepertoire Inc., a small disadvantaged business, for RNA sequencing services for mouse T cell receptor research. The contract has a total ceiling value of $13,230.00 and a period of performance through February 28, 2025. Irepertoire Inc. will provide services such as T-cell receptor sequencing,...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Irepertoire Inc., a small disadvantaged business, for T-cell receptor sequencing services. The contract has a potential value of $19,404.00 and a completion date of July 26, 2024. Irepertoire Inc. has previously provided a range of services to HHS and other federal agencies, including T-cell receptor...
- Irepertoire Inc. was awarded a $19,620 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide T cell receptor deep sequencing services. The contract has a period of performance through May 10, 2024 and was awarded on January 11, 2024 without a set-aside designation. As part of its mission to understand, treat, and ultimately prevent infectious, immunologic, and allergic...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $47,575.30 firm fixed price purchase order to Immudex USA, LLC for custom T-cell receptor reagents. Per the original solicitation, Immudex will provide design of relevant TCR constructs, protein expression, quality control, and final production of these reagents. The reagents will support identification and enumeration of antigen presenting...
- The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $12,764 purchase order to MP Biomedicals LLC. The firm fixed price order is to provide reagents to the Chuan Wu Lab at the National Cancer Institute required for their study of intestinal inflammation in mice. The reagents will support the lab's research being conducted under the National Cancer Institute's program focused on understanding disease...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $19,382.50 firm fixed price purchase order to Bio-Techne Sales Corporation of Minneapolis, Minnesota. The order is for ELISPOT KITS to be delivered between August 21, 2023 and September 20, 2023. The National Cancer Institute conducts and supports research into the causes, prevention, diagnosis, and treatment of cancer through its various programs and divisions. No set aside...
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $95,509.00, is for the procurement of one (1) I-DOT 2.0 dispensing system for the preparation of next-generation sequencing (NGS) library preps of T-cell receptors (TCRs) in support of cancer research. The contract was set aside for small businesses, and the prime...